Cypress Capital Management LLC / ABT
Cypress Capital Management LLC’s Abbott Laboratories Position
Does Cypress Capital Management LLC own Abbott Laboratories (ABT)? Not currently — the last reported position was 61.6K shares worth $6M in Q3 2022; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$6M
Q3 2022
Shares
61.6K
% of Portfolio
+1.11%
Quarters Held
15
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 61.6K | $6M | +1.11% |
| Q2 2022 | 61.7K | $7M | +1.00% |
| Q1 2022 | 62.0K | $7M | +0.92% |
| Q4 2021 | 62.8K | $9M | +1.00% |
| Q3 2021 | 63.0K | $7M | +0.97% |
| Q2 2021 | 63.0K | $7M | +0.96% |
| Q1 2021 | 63.1K | $8M | +1.04% |
| Q4 2020 | 195.6K | $21M | +2.92% |
| Q3 2020 | 194.3K | $21M | +3.24% |
| Q2 2020 | 194.4K | $18M | +2.90% |
| Q1 2020 | 196.4K | $15M | +3.04% |
| Q4 2019 | 202.1K | $18M | +2.69% |
| Q3 2019 | 203.8K | $17M | +2.79% |
| Q2 2019 | 203.4K | $17M | +2.97% |
| Q1 2019 | 199.4K | $16M | +2.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cypress Capital Management LLC’s full portfolio or all institutional holders of ABT.